NewCa.com: SHINGRIX approved in Canada for adults at increased
GlaxoSmithKline Inc. today announced that SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) has been approved in Canada for the prevention of shingles (herpes
Source: newca.com
Page 19 - Clinical Development Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Clinical Development Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Clinical Development Program Today - Breaking & Trending Today
Sobi to present new data at the ASH 2021 Annual Meeting
/PRNewswire/ -- Sobi™ will present new data at the 63rd Annual Meeting of the American Society of Hematology (ASH) taking place from 11-14 December 2021....
Source: prnewswire.com
Sobi to present new data at the ASH 2021 Annual Meeting
STOCKHOLM, Nov. 4, 2021 /PRNewswire/ -- Sobi will present new data at the 63rd Annual Meeting of the American Society of Hematology (ASH) taking place from 11-14 December 2021. Sobi's commitment
Source: finanznachrichten.de
Sobi to present new data at the ASH 2021 Annual Meeting
/PRNewswire/ -- Sobi™ will present new data at the 63rd Annual Meeting of the American Society of Hematology (ASH) taking place from 11-14 December 2021....
Source: prnewswire.com
Alkermes Initiates ARTISTRY-7 Phase 3 Trial of Nemvaleukin Alfa in Patients With Platinum-Resistant Ovarian Cancer
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the initiation of ARTISTRY-7, a global phase 3, open-label, randomized trial evaluating the...
Source: prnewswire.com